PRIMEGEN Trademark

Trademark Overview


On Thursday, February 13, 2025, a trademark application was filed for PRIMEGEN with the United States Patent and Trademark Office. The USPTO has given the PRIMEGEN trademark a serial number of 99041081. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 22, 2025. This trademark is owned by PrimeGen Biotech LLC. The PRIMEGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Stem cell research services
primegen

General Information


Serial Number99041081
Word MarkPRIMEGEN
Filing DateThursday, February 13, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesStem cell research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 13, 2025
Primary Code042
First Use Anywhere DateSaturday, April 1, 2000
First Use In Commerce DateSaturday, April 1, 2000

Trademark Owner History


Party NamePrimeGen Biotech LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSanta Ana, CA 92705

Trademark Events


Event DateEvent Description
Thursday, February 13, 2025NEW APPLICATION ENTERED
Thursday, February 13, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, July 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 22, 2025ASSIGNED TO EXAMINER
Tuesday, July 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 22, 2025NON-FINAL ACTION E-MAILED

Related Keywords


primegen services research cell stem